Gazi University

Ankara 6500

2 studies enrolling now · 15 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Beta-Galactosidase-1 (GLB1) Deficiency, Breast Cancer, CLL, Chronic Lymphocytic Leukemia, GM1 Gangliosidosis, GM1 Gangliosidosis, Type 2, GM1 Gangliosidosis, Type I, Graft Vs Host Disease, Leukemia, B-cell, Locally Advanced Breast Cancer, Lymphoma, B-Cell

Studies at this site

• Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death — Recruiting now
• A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors — Recruiting now
• Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL) — Running, not enrolling
• A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis — Running, not enrolling
• A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation — Running, not enrolling
• Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC — Completed
• Setrusumab vs Placebo for Osteogenesis Imperfecta — Running, not enrolling
• A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants — Completed
• This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2 — Completed
• Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. — Running, not enrolling
• Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) Patients — Completed
• Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma — Running, not enrolling
• Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A — Completed
• Stroke Inpatient Rehabilitation Reinforcement of ACTivity — Completed